📰 Optune Lua News
Page 4 - Optune Lua News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Optune Lua. Real-time updates on events, politics, business and more.
January 28, 2024
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been given an average rating of “Moderate Buy” by the eight brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have assigned a buy recommendation to […]
January 26, 2024
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight analysts that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have given a buy recommendation to […]
January 26, 2024
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy […]
January 24, 2024
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have received an average rating of “Moderate Buy” from the eight ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have given a buy recommendation to the […]
January 3, 2024
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have issued a buy recommendation on the company. […]
January 1, 2024
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 […]
December 14, 2023
Electromed (NYSE:ELMD – Get Free Report) and NovoCure (NASDAQ:NVCR – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 26.7% of Electromed shares are […]
December 14, 2023
NovoCure (NASDAQ:NVCR – Get Free Report) and Electromed (NYSE:ELMD – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Profitability This table compares NovoCure and Electromed’s net margins, […]
December 13, 2023
Siemens Healthineers (OTCMKTS:SEMHF – Get Free Report) and NovoCure (NASDAQ:NVCR – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Valuation & Earnings This table compares Siemens Healthineers and […]
December 4, 2023
NovoCure Limited (NASDAQ:NVCR – Get Free Report) shares shot up 6.2% during mid-day trading on Monday . The stock traded as high as $13.32 and last traded at $13.27. 559,039 shares were traded during mid-day trading, a decline of 60% from the average session volume of 1,386,767 shares. The stock had previously closed at $12.50. […]